This symposium, presented at SSEIM 2024, provides an overview of sepiapterin as a potential treatment for phenylketonuria (PKU) and its implications for patient management
The Society for the Study of Inborn Errors of Metabolism (SSIEM)
The Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium is a yearly conference bringing together clinicians and scientists to discuss the challenges and opportunities in the field of inborn errors of metabolism.
Please select the resource of interest below:
|
Congress
Topic
Type
Year
▼ Sepiapterin is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. Adverse events should also be reported to PTC Therapeutics at pharmacovigilance@ptcbio.com.
Registration conditions differ internationally; always consult local prescribing information and/or Summary of Product Characteristics before prescribing any products.
MED-ALL-PTC923-2500012 | September 2025
MED-ALL-PKU-2500224 | October 2025